Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: inside layer (24), coating (68), liner (5)

Parvovirus B19 during pregnancy - patient information

Description: This factsheet explains what parvovirus B19 is, the common symptoms and how catching this virus may affect you and your baby
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Parvovirus-B19-during-pregnancy-3648-PIL.pdf

Echogenic lung lesion - patient information

Description: This factsheet explains what an echogenic lung lesion (ELL) is, the possible causes and what this means for you and your
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Echogenic-lung-lesion-3592-PIL.pdf

How to contact the bronchiectasis service - patient information

Description: This flyer contains information about the Southampton bronchiectasis service.
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/How-to-contact-the-bronchiectasis-service-3479-PIL.pdf

Carboplatin (AUC5)-Pegylated Liposomal Doxorubicin (Caelyx)x)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) - DOXORUBICIN PEGYLATED LIPOSOMAL (Caelyx) Please note this protocol is based on information for the use
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Pegylated-Liposomal-DoxorubicinCaelyxVer1.pdf

Carboplatin (AUC5) Retreat

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat (AUC5) Regimen • Ovary – Carboplatin (AUC5) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Retreat.pdf

Bevacizumab (15) Carboplatin-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Bevacizumab (15)-Carboplatin (AUC5)-Paclitaxel (21 day) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Bevacizumab-15-Carboplatin-Paclitaxel-21-day.pdf

Carboplatin(AUC5)-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Carboplatin (AUC5)-Paclitaxel (21 day) Indication • Neoadjuvant treatment of cervical
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/CarboplatinAUC5-Paclitaxel-21day.pdf

SoAR RLP Deputy Lead Role JD and PS

Description: Southampton Academy of Research (SoAR) Research Leaders Programme (RLP) Deputy Lead: Call for expressions of interest University of Southampton NHS Foundation
Url: /Media/Southampton-Clinical-Research/Downloads/SoAR-RLP-Deputy-Lead-Role-JD-and-PS.pdf

Expressions of interest in SoAR Associate Director role JD and PS 24-4-2023

Description: Southampton Academy of Research (SoAR) Associate Director: Call for expressions of interest University of Southampton NHS Foundation Trust (UHSFT) and University
Url: /Media/Southampton-Clinical-Research/Downloads/Expressions-of-interest-in-SoAR-Associate-Director-role-JD-and-PS-24-4-2023.pdf

Workforce demographic 2023

Description: UHS Workforce Profile as of 31st March 2023 UHS is one of the largest employers in Southampton, with 13,704 staff
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/Workforce-demographic-2023.pdf

281 to 290 of 743

Previous … 27 28 29 30 31 … Next